EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Toll-like receptor 4 knockout mice are protected against PMOS-like pathogenesis

Kiara Wiggins, Zena Del Mundo, Julio Ayala Angulo, Nandini Naidu, Angelina Saba, Lily Zhou, Christopher Garcia, Christy M Nguyen, Naveena Ujagar, Jamie-Jean De La Torre, Gabriela De Robles, Angie Rivera und 8 weitere

Reproduction · 03.07.2026 · 172 (1)

DOI: 10.1093/reprod/xaag081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproduction, online erschienen am 22.07.2026. Verfasst von Kiara Wiggins und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California Irvine, Irvine, CA, United States. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Polycystic Ovary Syndrome. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIAMS NIH HHS, National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In brief: Polyendocrine metabolic ovarian syndrome (PMOS) is associated with metabolic, reproductive, and immune dysfunction, yet the mechanisms driving these abnormalities remain unclear. This study identifies Toll-like receptor 4 (TLR4) as a key contributor of PMOS-like pathology in mice, linking gut barrier disruption and endotoxin-associated immune activation to impaired metabolic and reproductive function. Abstract: Polyendocrine metabolic ovarian syndrome (PMOS), formerly termed polycystic ovary syndrome (PCOS), is a reproductive disorder with heterogeneous symptoms and severity. Despite extensive research documenting chronic immune dysfunction as a hallmark of PMOS, the specific mechanisms of immune activation remain poorly understood. Emerging evidence suggests that gut-derived bacterial endotoxins, particularly lipopolysaccharide (LPS), can breach intestinal barriers and trigger systemic inflammation via Toll-like receptor 4 (TLR4). This study examined the role of TLR4 in PMOS-like pathology using a letrozole (LET)-induced mouse model. In LET-treated wild-type female mice, serum LPS and its carrier protein lipopolysaccharide-binding protein (LBP) were elevated compared with LET-treated TLR4–/– mice. Additionally, TLR4 deficiency attenuated multiple PMOS-like features, including elevated luteinizing hormone, anovulation, and metabolic dysfunction. The LET-treated TLR4–/– mice also preserved estrous cycling and fertility, maintained gut barrier integrity, and reduced inflammatory markers. These findings support TLR4 as an important contributor to multiple features of PMOS-like pathology. This novel work highlights TLR4-mediated inflammation as a potential target for anti-inflammatory treatments in women with PMOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4Polycystic Ovary SyndromeAnimalsFemaleMiceMice, KnockoutLipopolysaccharidesIntestinal Barrier FunctionLetrozoleMice, Inbred C57BL

Stichwörter der Autor:innen

PCOSPMOSTLR4inflammationmetabolicreproduction

Substanzen

Toll-Like Receptor 4Tlr4 protein, mouseLipopolysaccharidesLetrozole

Autor:innen und Institutionen

  • Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California Irvine, Irvine, CA, United States.
  • Department of Biological Chemistry, University of California Irvine, Irvine, CA, United States.
  • Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, La Jolla, CA, United States.
  • Center for Obstetrics and Gynecology Research Innovation, University of California San Diego, La Jolla, CA, United States.
  • Division of Basic and Clinical Immunology, Department of Medicine, University of California, Irvine, Irvine, CA, United States.
  • Center for Epigenetics and Metabolism, University of California Irvine, Irvine, CA, United States.

ORCID-Profile: Anshu Agrawal, Gabriela Pacheco-Sanchez, Dequina A Nicholas

Förderung

  • NICHD NIH HHS
  • NIAMS NIH HHS
  • National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Wiggins, K., Del Mundo, Z., Angulo, J. A., Naidu, N., Saba, A., Zhou, L., Garcia, C., Nguyen, C. M., Ujagar, N., De La Torre, J. J., De Robles, G., Rivera, A., Trinh, D., Tinoco, R., Kauffman, A. S., Thackray, V. G., Agrawal, A., Seldin, M., Pacheco-Sanchez, G., & Nicholas, D. A. (2026). Toll-like receptor 4 knockout mice are protected against PMOS-like pathogenesis. Reproduction, 172(1). https://doi.org/10.1093/reprod/xaag081

Vancouver

Wiggins K, Del Mundo Z, Angulo JA, Naidu N, Saba A, Zhou L, et al. Toll-like receptor 4 knockout mice are protected against PMOS-like pathogenesis. Reproduction. 2026;172(1). doi:10.1093/reprod/xaag081

BibTeX
@article{Wiggins2026,
  author = {Wiggins, Kiara and Del Mundo, Zena and Angulo, Julio Ayala and Naidu, Nandini and Saba, Angelina and Zhou, Lily and Garcia, Christopher and Nguyen, Christy M and Ujagar, Naveena and De La Torre, Jamie-Jean and De Robles, Gabriela and Rivera, Angie and Trinh, Davina and Tinoco, Roberto and Kauffman, Alexander S and Thackray, Varykina G and Agrawal, Anshu and Seldin, Marcus and Pacheco-Sanchez, Gabriela and Nicholas, Dequina A},
  title = {Toll-like receptor 4 knockout mice are protected against PMOS-like pathogenesis},
  journal = {Reproduction},
  year = {2026},
  volume = {172},
  number = {1},
  doi = {10.1093/reprod/xaag081}
}
Kostenlos starten →